Polycystic ovary syndrome develops from a tangle of genetic predisposition, hormonal feedback loops, metabolic dysfunction, and environmental triggers rather than any single cause. Roughly 40% of sisters of affected women also develop the condition, pointing to a strong inherited component, but genes alone don’t explain the full picture. Insulin resistance, chronic low-grade inflammation, prenatal hormone exposure, and even gut bacteria all play contributing roles, and these factors interact with each other in ways researchers are still mapping out.
The Genetic Foundation
PCOS runs in families, and the pattern is hard to miss. Early family studies estimated that a woman’s risk of developing the syndrome is about 40% if her sister has it, and the inheritance pattern looks consistent with a major gene effect passed down in an autosomal dominant fashion, though with a wide range of how it actually shows up from person to person.1PubMed. The development of the polycystic ovary syndrome: family history as a risk factor That same research found only about 19% of mothers were affected, hinting the condition may be preferentially inherited through the father’s side, though this hasn’t been firmly confirmed in larger studies.
Genome-wide association studies have since identified a number of candidate gene regions tied to the condition. These include genes involved in the receptors for two key reproductive hormones (luteinizing hormone and follicle-stimulating hormone), the insulin receptor, and several other loci involved in cell growth and hormone signaling.2PubMed Central. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria The genetic variants identified so far are associated with higher androgen levels and disrupted gonadotropin regulation, which are hallmarks of the syndrome.2PubMed Central. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria But each individual variant carries only a small effect, and together they still explain only a fraction of who gets PCOS and who doesn’t. That gap between genetic risk and actual disease is where everything else on this list comes in.
Insulin Resistance and the Androgen Spiral
If genetics loads the gun, insulin resistance often pulls the trigger. When your body’s cells don’t respond well to insulin, the pancreas compensates by producing more of it. That excess insulin doesn’t just affect blood sugar. It directly stimulates the ovaries and, to a lesser extent, the adrenal glands to pump out more androgens. At the same time, high insulin suppresses production of sex hormone-binding globulin in the liver, which is the protein that keeps androgens in check by binding them up in the bloodstream. The result is a double hit: more androgens being made and more of them circulating in their active, unbound form.3PubMed Central. Total testosterone significantly correlates with insulin resistance in polycystic ovary syndrome
The relationship works both ways, which is what makes it so persistent. Excess androgens promote the accumulation of visceral fat, and visceral fat itself worsens insulin resistance, which drives more androgen production. Androgens also inhibit the breakdown of fat while promoting its storage, compounding the metabolic problem.4PubMed Central. PCOS and nutritional approaches: Differences between lean and obese phenotype Obesity then amplifies the whole cycle: women with PCOS who are obese tend to have significantly higher insulin levels, greater insulin resistance, and worse lipid profiles compared to lean women with the same PCOS phenotype.5PubMed Central. Comparing Lean and Obese PCOS in Different PCOS Phenotypes: Evidence That the Body Weight Is More Important than the Rotterdam Phenotype in Influencing the Metabolic Status This is why weight management often (though not always) improves symptoms, and why PCOS is so closely linked with metabolic syndrome.
A Signal From the Brain
The story doesn’t start in the ovaries alone. A region of the brain called the hypothalamus sends out pulses of gonadotropin-releasing hormone (GnRH), which tells the pituitary gland how much luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to produce. In women with PCOS, GnRH pulses are roughly 40% faster than normal, firing about once per hour instead of every 90 minutes.6PubMed Central. Targeting Elevated GnRH Pulsatility to Treat Polycystic Ovary Syndrome That faster rhythm favors LH production over FSH. Since LH drives the ovarian theca cells to make androgens while FSH is needed for follicle maturation, the imbalance helps explain both the excess androgens and the stalled follicle development that gives the ovaries their characteristic “polycystic” appearance on ultrasound.
On top of the ovarian contribution, roughly 20 to 30% of women with PCOS also have excess androgen production from the adrenal glands.7PubMed. The adrenal and polycystic ovary syndrome This adrenal hyperandrogenism appears to stem from the adrenal glands being overly sensitive to ACTH, the hormone that normally stimulates cortisol production.8PubMed Central. The significance of functional adrenal hyperandrogenism in polycystic ovary syndrome across the lifespan Women with this adrenal component tend to have elevated levels of DHEA-S, a specific adrenal androgen. This means not all the excess testosterone in PCOS comes from the ovaries, which partly explains why different women respond differently to treatments that target only ovarian androgen production.
Chronic Inflammation as a Driver
Low-grade inflammation is a consistent finding in PCOS, and it appears to be more than just a side effect. Laboratory studies have shown that inflammatory signals can directly stimulate the enzyme in ovarian theca cells responsible for producing androgens, suggesting inflammation itself can push androgen levels higher.9PubMed Central. Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction One proposed mechanism involves excess androgens causing fat cells to enlarge (hypertrophy), which compresses tiny blood vessels in fat tissue and creates local oxygen deprivation. That oxygen-starved tissue then triggers inflammatory pathways, which feed right back into more androgen production.10PubMed Central. The Role of Chronic Inflammation in Polycystic Ovarian Syndrome—A Systematic Review and Meta-Analysis
Inflammation also worsens insulin resistance independently, meaning it reinforces the metabolic feedback loop described earlier. The picture that emerges is one of multiple vicious cycles interlocking: insulin resistance raises androgens, androgens promote inflammation, inflammation worsens insulin resistance, and around it goes. Breaking into any part of this cycle, whether through medication, weight loss, or anti-inflammatory approaches, can improve the whole picture.
Prenatal Programming and Epigenetic Inheritance
Some of the groundwork for PCOS may be laid before birth. Animal studies have consistently shown that exposing female fetuses to elevated androgens during critical windows of development can produce a PCOS-like syndrome in adulthood, complete with irregular cycles, polycystic ovarian morphology, and metabolic abnormalities.11PubMed Central. The time of prenatal androgen exposure affects development of polycystic ovary syndrome-like phenotype in adulthood in female rats The timing of exposure matters: androgens during specific developmental windows caused the most pronounced effects on later reproductive and hormonal health.
Even more striking, mouse research has found that these effects can be passed down across generations through epigenetic changes, specifically alterations in DNA methylation patterns. In one study, mice exposed to excess anti-Müllerian hormone (AMH) during pregnancy produced daughters and granddaughters with PCOS-like traits, and the methylation changes showed up across multiple tissues, including the ovaries, the hypothalamus, and visceral fat.12Cell Metabolism. Cell Metabolism – Discussion If similar mechanisms operate in humans, and there’s growing reason to think they do, then a mother’s hormonal environment during pregnancy could shape her daughter’s risk of PCOS decades later, independent of classical genetic inheritance.
Environmental Chemicals
Endocrine-disrupting chemicals, particularly bisphenol A (BPA) and its structural relatives, are attracting increasing attention as environmental contributors to PCOS. BPA is found in plastics, food can linings, and thermal receipt paper, and it mimics estrogen in the body while also interfering with androgen metabolism and insulin signaling. With daily exposure, BPA can bioaccumulate and activate signaling pathways that promote hyperandrogenism, insulin resistance, and chronic inflammation.13PubMed Central. Does bisphenol A (BPA) participates in the pathogenesis of Polycystic Ovary Syndrome (PCOS)?
A multicenter case-control study of women of childbearing age found statistically significant associations between several bisphenol compounds and increased odds of PCOS. BPA itself was associated with about a 9% increase in odds per unit increase in exposure, while BPS (a common BPA substitute marketed as safer) showed an 18% increase.14Chemosphere. Exposure to bisphenol A and its analogs and polycystic ovarian syndrome in women of childbearing age: A multicenter case-control study These chemicals were also positively correlated with testosterone levels in both affected and unaffected women. The fact that BPA substitutes show similar or even stronger associations is worth noting: switching to “BPA-free” products doesn’t necessarily reduce exposure to compounds with similar hormonal effects.
The Gut Microbiome Connection
An area of research that’s expanded rapidly is the link between gut bacteria and PCOS. Women with the syndrome tend to have measurable differences in their gut microbiome composition, including shifts in the ratio of major bacterial groups and an increase in certain inflammation-associated species. These microbial changes appear to influence insulin secretion, androgen metabolism, and follicle development through multiple pathways.15PubMed Central. Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications
Specific bacteria associated with dysbiosis in PCOS patients include certain strains linked to systemic inflammation and altered hormone levels, which can worsen clinical symptoms.16PubMed Central. Gut microbiota: a hidden player in polycystic ovary syndrome The gut-brain axis also comes into play: metabolites produced by gut bacteria, including short-chain fatty acids and bacterial toxins like lipopolysaccharides, can influence hypothalamic function and inflammatory tone throughout the body. This is still an emerging field, and it’s not yet clear whether gut dysbiosis is a cause of PCOS, a consequence of the metabolic and hormonal disturbances, or both. But it opens up the possibility that interventions targeting the microbiome, whether through diet, probiotics, or other means, could eventually become part of the treatment toolkit.
When PCOS Typically Emerges
PCOS most commonly becomes apparent during puberty, which makes diagnosis tricky because normal puberty itself involves some of the same features. During the transition into reproductive maturity, healthy girls can have irregular periods, mild acne, slightly elevated androgens, and ovaries that look “multi-follicular” on ultrasound. These are normal features of a maturing reproductive system.17PubMed Central. Intertwined reproductive endocrinology: Puberty and polycystic ovary syndrome The overlap means that many cases of PCOS go unrecognized during adolescence, dismissed as “normal puberty stuff,” while other girls who simply have a slower maturation pattern get mistakenly told they have PCOS. Current guidelines recommend waiting at least two years after the first period before applying PCOS diagnostic criteria, since many features that look like PCOS in early puberty resolve on their own.
There’s also a subset of women who don’t notice symptoms until they’re trying to conceive in their late twenties or thirties. In some cases the syndrome was present all along but masked by hormonal contraceptives; in others, weight gain or other metabolic changes in adulthood may have tipped an existing predisposition into a clinical presentation.
Why PCOS Looks Different Across Populations
PCOS doesn’t look the same in everyone, and some of the variation tracks with racial and ethnic background. In one study comparing women with PCOS across groups, Hispanic women had significantly higher rates of hirsutism, worse insulin resistance, and more hyperglycemia than non-Hispanic White women. Non-Hispanic Black women, by contrast, had a markedly lower prevalence of metabolic syndrome and dramatically lower rates of high triglycerides compared to both Hispanic and non-Hispanic White women with the condition.18PubMed Central. Racial and Ethnic Differences in the Polycystic Ovary Syndrome Metabolic Phenotype
These differences likely reflect a combination of genetic variation, differences in body fat distribution, dietary patterns, and disparities in healthcare access and diagnosis timing.19PubMed Central. Racial and ethnic disparities in polycystic ovary syndrome They also mean that a woman’s experience of PCOS can vary substantially depending on her background, and screening tools or treatment protocols developed primarily in one population don’t always translate well to others.
PCOS in Lean Women
One of the most persistent misconceptions about PCOS is that it only affects overweight women. In reality, a significant minority of women with PCOS are lean or normal weight. While the metabolic disruptions are typically less severe in lean women, they’re still present. Lean women with PCOS still show higher insulin and insulin resistance markers compared to unaffected women of similar weight, though the differences are less dramatic than in their obese counterparts.5PubMed Central. Comparing Lean and Obese PCOS in Different PCOS Phenotypes: Evidence That the Body Weight Is More Important than the Rotterdam Phenotype in Influencing the Metabolic Status This matters because lean women with PCOS symptoms are frequently told by doctors that they “can’t” have PCOS because of their weight, leading to delayed diagnosis and treatment.
The evidence suggests that body weight is actually a more powerful predictor of how severe the metabolic problems will be than which specific PCOS phenotype a woman has. Across all major PCOS subtypes, obese women consistently had worse insulin resistance, worse lipid profiles, and lower anti-Müllerian hormone levels than lean women with the same subtype.5PubMed Central. Comparing Lean and Obese PCOS in Different PCOS Phenotypes: Evidence That the Body Weight Is More Important than the Rotterdam Phenotype in Influencing the Metabolic Status Obesity amplifies PCOS, but it doesn’t cause it.
Conditions That Mimic PCOS
Part of understanding how PCOS develops means understanding what it isn’t. A diagnosis of PCOS is technically a diagnosis of exclusion: you arrive at it by first ruling out other conditions that produce similar symptoms. The most clinically important look-alike is nonclassic congenital adrenal hyperplasia (NC-CAH), an inherited enzyme deficiency in the adrenal glands. NC-CAH causes excess androgens, hirsutism, irregular periods, and even polycystic-appearing ovaries on ultrasound, making it nearly indistinguishable from PCOS on clinical grounds alone.20PubMed Central. Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review
In one screening study, about 12.5% of women initially suspected to have PCOS were found after hormonal testing to actually have genetically confirmed congenital adrenal hyperplasia.21PubMed. Adrenal steroid profiling as a diagnostic tool to differentiate polycystic ovary syndrome from nonclassic congenital adrenal hyperplasia The single most useful blood test to distinguish the two is a baseline measurement of 17-hydroxyprogesterone, a hormone precursor that’s elevated in NC-CAH but normal in PCOS.22PubMed Central. Clinical, Metabolic and Hormonal Overlap Between Nonclassic Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome: An Exploratory Study Other conditions that need to be ruled out include thyroid disorders, elevated prolactin levels, and androgen-producing tumors. Getting the right diagnosis matters because the treatments differ substantially.
Dietary Compounds and Advanced Glycation End Products
Beyond macronutrient balance and calorie intake, the specific chemistry of what you eat may matter for PCOS. Advanced glycation end products (AGEs) are compounds formed when proteins or fats are exposed to sugars, particularly during high-heat cooking methods like frying, grilling, and roasting. Women with PCOS tend to have elevated levels of AGEs in their blood, and these compounds are associated with worse insulin resistance. AGEs also accumulate in ovarian tissue, where they appear to contribute to anovulation and further androgen production.23PubMed Central. Contribution of Advanced Glycation End Products to PCOS Key Elements: A Narrative Review Diets heavy in processed and charred foods tend to be higher in AGEs, while cooking methods like steaming, boiling, or slow-cooking at lower temperatures produce fewer of them. This offers one specific dietary lever that goes beyond generic advice about “eating healthy.”
Night Shifts and Circadian Disruption
An underappreciated risk factor is working against your body’s internal clock. A study of women of reproductive age found that night shift work was associated with roughly double the odds of PCOS after adjusting for other risk factors, and the association was strongest in women who had worked night shifts for more than two years.24Fertility and Sterility. Association of circadian rhythm disruption with polycystic ovary syndrome Rotating schedules (where the shift changes from week to week) appeared to carry a higher risk than permanent night shifts, possibly because the body at least partially adapts to a consistent nighttime schedule but struggles with constant change. Circadian rhythm disruption affects cortisol release, melatonin levels, and insulin sensitivity, all of which feed into the hormonal and metabolic pathways already implicated in PCOS.
An Evolutionary Mismatch
Given how common PCOS is and how many genes contribute to it, evolutionary biologists have asked why natural selection hasn’t weeded these variants out. One hypothesis is that the traits associated with PCOS, including relative insulin resistance and higher androgen levels, may have conferred survival advantages under ancestral conditions of food scarcity. The idea is that women with these traits might have been better at maintaining ovarian function during famine, storing energy in visceral fat that could be mobilized in lean times, and developing greater muscularity for physical demands.25PubMed Central. The Endocrinological Basis for Polycystic Ovary Syndrome: An Evolutionary Perspective
An alternative framing, and the one with more cautious support, is that PCOS gene variants may never have been actively beneficial but simply drifted in the population because they weren’t harmful enough under past conditions to be selected against. Under modern conditions of caloric abundance and sedentary lifestyles, those previously silent variants now interact with the environment to produce the full clinical syndrome.26Evolution, Medicine, and Public Health. Evolutionary origins of polycystic ovary syndrome: An environmental mismatch disorder Neither hypothesis has been definitively proven, but both help explain why PCOS affects such a large fraction of women worldwide and why its severity seems so responsive to lifestyle and environmental factors. The condition may not be a single “disease” so much as an inherited metabolic tendency whose expression depends heavily on context.